LQLY — Qly Biotech Cashflow Statement
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
Annual cashflow statement for Qly Biotech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.001 | -0.005 | -0.029 | -0.014 |
| Depreciation | ||||
| Amortisation | ||||
| Changes in Working Capital | — | — | 0.002 | -0.002 |
| Change in Accounts Payable | ||||
| Cash from Operating Activities | -0.001 | -0.004 | -0.026 | -0.014 |
| Capital Expenditures | — | -0.005 | 0 | — |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | — | -0.005 | 0 | — |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.006 | 0.032 | 0.004 | 0.009 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.005 | 0.023 | -0.022 | -0.005 |